Literature DB >> 10658955

Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life.

S J Lupien1, N P Nair, S Brière, F Maheu, M T Tu, M Lemay, B S McEwen, M J Meaney.   

Abstract

Perhaps the most prominent feature of human aging is the variability in decline of intellectual processes. Although many research avenues have been used to study the origin of such an increased variability with aging, new studies show that some biological factors may be associated with normal and pathological cognitive aging. One biological parameter that came under scrutiny in the past few years is the hypothalamic-pituitary-adrenal (HPA) axis, an endocrine closed-loop system controlling the secretion of stress hormones (glucocorticoids). In this review, we summarize data obtained in both animals and humans suggesting that cumulative exposure to high levels of glucocorticoids can be particularly detrimental for the aged hippocampus, a brain structure involved in learning and memory in both animals and humans. We then analyze the implication of these data for the study of dementia and depression in later life, two disorders characterized by increased glucocorticoid secretion in a significant proportion of patients. Finally, we suggest various factors that could explain the development of glucocorticoid hypersecretion in later life.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10658955     DOI: 10.1515/revneuro.1999.10.2.117

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  67 in total

1.  Effects of developmental stress and lead (Pb) on corticosterone after chronic and acute stress, brain monoamines, and blood Pb levels in rats.

Authors:  Devon L Graham; Curtis E Grace; Amanda A Braun; Tori L Schaefer; Matthew R Skelton; Peter H Tang; Charles V Vorhees; Michael T Williams
Journal:  Int J Dev Neurosci       Date:  2010-10-08       Impact factor: 2.457

2.  The Douglas Hospital Longitudinal Study of Normal and Pathological Aging: summary of findings.

Authors:  Sonia J Lupien; Georges Schwartz; Ying Kin Ng; Alexandra Fiocco; Nathalie Wan; Jens C Pruessner; Michael J Meaney; N P Vasavan Nair
Journal:  J Psychiatry Neurosci       Date:  2005-09       Impact factor: 6.186

3.  Salivary cortisol and prefrontal cortical thickness in middle-aged men: A twin study.

Authors:  William S Kremen; Robert C O'Brien; Matthew S Panizzon; Elizabeth Prom-Wormley; Lindon J Eaves; Seth A Eisen; Lisa T Eyler; Richard L Hauger; Christine Fennema-Notestine; Bruce Fischl; Michael D Grant; Dirk H Hellhammer; Amy J Jak; Kristen C Jacobson; Terry L Jernigan; Sonia J Lupien; Michael J Lyons; Sally P Mendoza; Michael C Neale; Larry J Seidman; Heidi W Thermenos; Ming T Tsuang; Anders M Dale; Carol E Franz
Journal:  Neuroimage       Date:  2010-02-13       Impact factor: 6.556

4.  Change in stress and social support as predictors of cognitive decline in older adults with and without depression.

Authors:  Whitney J Dickinson; Guy G Potter; Celia F Hybels; Douglas R McQuoid; David C Steffens
Journal:  Int J Geriatr Psychiatry       Date:  2011-03-02       Impact factor: 3.485

5.  Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure.

Authors:  P J Lucassen; M B Müller; F Holsboer; J Bauer; A Holtrop; J Wouda; W J Hoogendijk; E R De Kloet; D F Swaab
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

6.  3xTg-AD mice exhibit an activated central stress axis during early-stage pathology.

Authors:  Elaine K Hebda-Bauer; Tracy A Simmons; Andrew Sugg; Eren Ural; James A Stewart; James L Beals; Qiang Wei; Stanley J Watson; Huda Akil
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  Antiglucocorticoid therapy for older adults with anxiety and co-occurring cognitive dysfunction: results from a pilot study with mifepristone.

Authors:  Eric J Lenze; Tamara Hershey; John W Newcomer; Jordan F Karp; Daniel Blumberger; Jennifer Anger; Peter Doré; David Dixon
Journal:  Int J Geriatr Psychiatry       Date:  2014-03-14       Impact factor: 3.485

8.  11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics.

Authors:  Thekkepat C Sandeep; Joyce L W Yau; Alasdair M J MacLullich; June Noble; Ian J Deary; Brian R Walker; Jonathan R Seckl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

9.  Episodic memory impairment in Addison's disease: results from a telephonic cognitive assessment.

Authors:  Michelle Henry; Kevin G F Thomas; Ian L Ross
Journal:  Metab Brain Dis       Date:  2014-02-27       Impact factor: 3.584

Review 10.  The potential effects of meditation on age-related cognitive decline: a systematic review.

Authors:  Tim Gard; Britta K Hölzel; Sara W Lazar
Journal:  Ann N Y Acad Sci       Date:  2014-01       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.